Search research articles
Contact Us
Filters
Showing results (211-220 of 244) with videos related to
Page
of 25
Sort By:
Biochemical Pharmacology
|
October 12, 1995
Biochemical pharmacology of penclomedine (NSC-338720)
J A Benvenuto, W N Hittelman, L A Zwelling, et al.
Hematology and Cell Therapy
|
December 1, 1996
Clinical experience with fludarabine in hemato-oncology
M J Keating, S O'Brien, P McLaughlin, et al.
Seminars in Oncology
|
October 1, 1993
Fludarabine: pharmacokinetics, mechanisms of action, and rationales for combination therapies
W Plunkett, V Gandhi, P Huang, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications
|
October 24, 2000
High-performance liquid chromatography method for the determination and quantitation of arabinosylguanine triphosphate and fludarabine triphosphate in human cells
C O Rodriguez, W Plunkett, M T Paff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2000
Pharmacokinetics of nelarabine and 9-beta-D-arabinofuranosyl guanine in pediatric and adult patients during a phase I study of nelarabine for the treatment of refractory hematologic malignancies
D F Kisor, W Plunkett, J Kurtzberg, et al.
Leukemia & Lymphoma
|
September 24, 1999
Phase I study of arabinosyl-5-azacytidine (fazarabine) in adult acute leukemia and chronic myelogenous leukemia in blastic phase
M Wilhelm, S O'Brien, M B Rios, et al.
Cancer
|
October 1, 1993
Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphocytic leukemia
S Suki, H Kantarjian, V Gandhi, et al.
Cancer
|
January 28, 1999
Complete hematologic and cytogenetic response to 2-amino-9-beta-D-arabinosyl-6-methoxy-9H-guanine in a patient with chronic myelogenous leukemia in T-cell blastic phase: a case report and review of the literature
A Aguayo, J E Cortes, H M Kantarjian, et al.
Journal of the American Academy of Dermatology
|
November 27, 2002
A nonfatal case and 2 fatal cases of paraneoplastic pemphigus: can a complement indirect immunofluorescent test help to identify fatal "group A" paraneoplastic pemphigus cases?
Ernst H Beutner, Stephen Pelton, Takashi Hashimoto, et al.
Leukemia & Lymphoma
|
May 1, 1993
High-dose cytosine arabinoside in chronic lymphocytic leukemia: a clinical and pharmacologic analysis
L E Robertson, R Hall, M J Keating, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 244) with videos related to
Sort By:
Page
of 25
Biochemical Pharmacology
|
October 12, 1995
Biochemical pharmacology of penclomedine (NSC-338720)
J A Benvenuto, W N Hittelman, L A Zwelling, et al.
Hematology and Cell Therapy
|
December 1, 1996
Clinical experience with fludarabine in hemato-oncology
M J Keating, S O'Brien, P McLaughlin, et al.
Seminars in Oncology
|
October 1, 1993
Fludarabine: pharmacokinetics, mechanisms of action, and rationales for combination therapies
W Plunkett, V Gandhi, P Huang, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications
|
October 24, 2000
High-performance liquid chromatography method for the determination and quantitation of arabinosylguanine triphosphate and fludarabine triphosphate in human cells
C O Rodriguez, W Plunkett, M T Paff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2000
Pharmacokinetics of nelarabine and 9-beta-D-arabinofuranosyl guanine in pediatric and adult patients during a phase I study of nelarabine for the treatment of refractory hematologic malignancies
D F Kisor, W Plunkett, J Kurtzberg, et al.
Leukemia & Lymphoma
|
September 24, 1999
Phase I study of arabinosyl-5-azacytidine (fazarabine) in adult acute leukemia and chronic myelogenous leukemia in blastic phase
M Wilhelm, S O'Brien, M B Rios, et al.
Cancer
|
October 1, 1993
Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphocytic leukemia
S Suki, H Kantarjian, V Gandhi, et al.
Cancer
|
January 28, 1999
Complete hematologic and cytogenetic response to 2-amino-9-beta-D-arabinosyl-6-methoxy-9H-guanine in a patient with chronic myelogenous leukemia in T-cell blastic phase: a case report and review of the literature
A Aguayo, J E Cortes, H M Kantarjian, et al.
Journal of the American Academy of Dermatology
|
November 27, 2002
A nonfatal case and 2 fatal cases of paraneoplastic pemphigus: can a complement indirect immunofluorescent test help to identify fatal "group A" paraneoplastic pemphigus cases?
Ernst H Beutner, Stephen Pelton, Takashi Hashimoto, et al.
Leukemia & Lymphoma
|
May 1, 1993
High-dose cytosine arabinoside in chronic lymphocytic leukemia: a clinical and pharmacologic analysis
L E Robertson, R Hall, M J Keating, et al.
Page
of 25